Pulmonary Drug Delivery Devices/Systems Market 2028 By Product By Application and By End User | The Insight Partners

MARKET INTRODUCTION

Pulmonary drug delivery devices or systems includes devices for delivering drugs through medical devices such as inhalers and nebulizers in patients with respiratory illnesses such as asthma. The devices are based on diverse delivery mechanisms and consist of types of drug formulations. Asthma, COPD, Allergic Rhinitis and Cystic Fibrosis are major respiratory diseases which require the use of drug delivery devices in case of emergency as well.

MARKET SCOPE

The "Pulmonary Drug Delivery Devices Systems Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pulmonary drug delivery devices systems market with detailed market segmentation by product, application, end user, and geography. The pulmonary drug delivery devices systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pulmonary drug delivery devices systems market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  Based on the product pulmonary drug delivery devices systems market is segmented as Metered dose inhalers (MDIs), Dry powder inhalers (DPIs, Nebulizers and Accessories.

  Based on application, the market is segmented into asthma, COPD, allergic rhinitis, cystic fibrosis and others

  Based on the end use the market is segmented as hospitals & clinics and home healthcare.

MARKET DYNAMICS

Drivers

•   Rising prevalence of respiratory diseases and growing healthcare expenditure.
  
•   Rising healthcare awareness and increasing technological advancements
  
•   Uses of respiratory care devices as a part of home healthcare
  

Restraints

•   Regulatory hurdles.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pulmonary Drug Delivery Devices Systems market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pulmonary Drug Delivery Devices Systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pulmonary Drug Delivery Devices Systems market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pulmonary Drug Delivery Devices Systems market in these regions.

IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY DEVICES SYSTEMS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The pulmonary drug delivery devices systems market registered a growth in COVID-19 pandemic times as more physician worked on investigating the respiratory health of the virus affected people.

MARKET PLAYERS

The report covers key developments in the Pulmonary Drug Delivery Devices Systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pulmonary Drug Delivery Devices Systems market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pulmonary Drug Delivery Devices Systems in the global market. Below mentioned is the list of few companies engaged in the Pulmonary Drug Delivery Devices Systems market.

The report also includes the profiles of key players in Pulmonary Drug Delivery Devices Systems market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   GlaxoSmithKline plc.
  
•   Koninklijke Philips N.V.
  
•   Boehringer Ingelheim International GmbH
  
•   3M
  
•   AstraZeneca
  
•   Teva Pharmaceutical Industries Ltd.
  
•   Aerogen Ltd.
  
•   Hovione
  
•   Hantel Technologies
  
•   H&T Presspart Manufacturing Ltd..
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.